x
Filter:
Filters applied
- Psoriasis
- DEGRemove DEG filter
- T helperRemove T helper filter
Publication Date
Please choose a date range between 2016 and 2018.
Keyword
- differentially expressed gene2
- CTLA41
- cytotoxic T-lymphocyte-associated protein 41
- false discovery rate1
- FDR1
- gene set variation analysis1
- GSVA1
- K161
- keratin 161
- lipopolysaccharide1
- LPS1
- NET1
- neutrophil extracellular trap1
- PASI1
- PBMC1
- peripheral blood mononuclear cells1
- phorbol myristate acetate1
- PMA1
- Psoriasis Area and Severity Index1
- regulator T cell1
- TH1
- Th1
- Treg1
Psoriasis
2 Results
- Original Article Clinical Research: PathophysiologyOpen Archive
Neutrophil Extracellular Traps Induce Human Th17 Cells: Effect of Psoriasis-Associated TRAF3IP2 Genotype
Journal of Investigative DermatologyVol. 139Issue 6p1245–1253Published online: December 5, 2018- Sylviane Lambert
- Caely A. Hambro
- Andrew Johnston
- Philip E. Stuart
- Lam C. Tsoi
- Rajan P. Nair
- and others
Cited in Scopus: 40Psoriasis lesions are rich in IL-17–producing T cells as well as neutrophils, which release webs of DNA-protein complexes known as neutrophil extracellular traps (NETs). Because we and others have observed increased NETosis in psoriatic lesions, we hypothesized that NETs contribute to increased T helper type 17 (Th17) cells in psoriasis. After stimulating peripheral blood mononuclear cells with anti-CD3/CD28 beads for 7 days, we found significantly higher percentages of CD3+CD4+IL-17+ (Th17) cells in the presence versus absence of NETs, as assessed by flow cytometry, IL-17 ELISA, and IL17A/F and RORC mRNAs. - Original Article Immunology/InfectionOpen Archive
The Spectrum of Mild to Severe Psoriasis Vulgaris Is Defined by a Common Activation of IL-17 Pathway Genes, but with Key Differences in Immune Regulatory Genes
Journal of Investigative DermatologyVol. 136Issue 11p2173–2182Published online: May 13, 2016- Jaehwan Kim
- Robert Bissonnette
- Jongmi Lee
- Joel Correa da Rosa
- Mayte Suárez-Fariñas
- Michelle A. Lowes
- and others
Cited in Scopus: 35Mild versus severe psoriasis is often distinguished by clinical measures such as the extent of skin involvement or Psoriasis Area and Severity Index score, both of which use arbitrary boundaries. It is widely assumed that severe psoriasis involves higher levels of skin inflammation, but comparative molecular profiles of mild versus severe disease have not been performed. In this study, we used immunohistochemistry, reverse transcription PCR, and gene arrays to determine the phenotype of North American patients with mild psoriasis (n = 34, mean PASI score = 5.5) versus severe psoriasis (n = 23, mean PASI score = 23.2).